Mark Blostein
Associate Member
Psychiatry
McGill University
Canada
Biography
Jewish General Hospital
Research Interest
Currently, my laboratory has three distinct focuses: 1) In vivo and in vitro characterization of gas6, a novel survival factor in endothelial cell physiology. 2) The design of hemostatic peptides to accelerate hemostasis and mitigate bleeding. This is a project funded by the Department of National Defense of Canada. 3) A collaborative study with the laboratory of Dr. Galipeau aimed at designing a novel gene therapeutic platform to treat hemophilia B.
Publications
-
Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis. Aghourian MN, Lemarié CA, Bertin FR, Blostein MD.
-
A multicenter prospective study of risk factors and treatment of unusual site thrombosis. Ma K, Wells P, Guzman C, Anderson D, Blostein M, Hirsch A, Lazo-Langner A, Kovacs MJ, Rodger M, Tagalakis V, Kahn SR.
-
Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis. Laurance S, Bertin FR, Ebrahimian T, Kassim Y, Rys RN, Lehoux S, Lemarié CA, Blostein MD.
